Introduction
Rasmussen's encephalitis (RE) is a rare, focal and progressive inflammatory disorder of unknown aetiology, resulting in unilateral hemispheric atrophy, contralateral hemiparesis and hemianopia, dysphasia with language-dominant hemispheric involvement and intractable epilepsy. RE is associated with polymorphic seizure types including epilepsia partialis continua (EPC) [1] . Current treatment strategies principally involve the combined use of corticosteroids, intravenous immunoglobulin (IVIG) and in adults, plasma exchange (PEX) although the response is variable and may be short-lived. Other treatments with greater efficacy and the potential to alter the natural history of RE are needed. Rituximab, a chimeric monoclonal antibody against CD20, has shown promise in RE although reports of its use in this disorder are few. Here, we present an unusual case of language-induced reflex seizures occurring in the context of adult-onset Rasmussen's encephalitis and report on the clinical response to immunomodulation and the efficacy of Rituximab.
Case study
At the age of 43 years, the patient presented with focal seizures consisting of speech and behavioural arrest of 30 s duration. Following seizure freedom for many years at the age of 51 years, aphasic focal seizures reoccurred with intractability. These consisted of episodes whereby during conversation she became unable to understand what was said to her or respond verbally, though clearly fully aware, and found this very distressing. These seizures were consistently precipitated by listening to speech and conversation and were debilitating such that she was unable to listen to the radio, watch television or use the telephone. She also reported focal motor seizures of her right arm and leg which arose either independently or followed her habitual aphasic seizures and would on occasion evolve into generalised convulsions with post-ictal right arm weakness. Inter-ictally she noted progressive word finding difficulties, a reduction in speech output and decline in arithmetic ability. Despite only a mild right hemiparesis she reported significant functional impairment of the right arm.
An MRI brain revealed left hemispheric atrophy, especially involving the left sylvian fissure, left superior temporal gyrus and head of the caudate nucleus ( Fig. 1) . A contemporaneous EEG showed spike and polyspike discharges maximal over the central region with a left-sided emphasis (Fig. 2) .
Epileptic discharges together with aphasic seizures were consistently induced when words or sentences were spoken to her, but were not evident when she spoke or repeated a word or a non-language sound. Elementary sounds, startle, listening to music, mathematical calculations and drawing failed to elicit epileptic discharges. CSF examination showed mildly elevated protein only. Immunological studies using rat cortex identified CSF antibodies against multiple proteins with strongest binding to a band at 120 kDa. FDG PET scan demonstrated reduced tracer uptake in the left hemisphere. Neuropsychometric testing after seizures showed marked deterioration of language functions, in particular a severe impairment in verbal fluency and word retrieval difficulties.
The patient's clinical features were sufficient for a diagnosis of Rasmussen's encephalitis in accordance with the European Consensus Diagnostic Criteria for RE thus obviating the need for a brain biopsy [2] . Courses of monthly IVIG combined with intravenous methylprednisolone resulted in a sustained improvement in seizures and interictal deficit such that she regained speech fluency. Maintenance steroids were avoided as she had type 2 diabetes. She deteriorated again aged 61 and concurrently was diagnosed with a myelodysplastic syndrome for which she required regular blood and platelet transfusions. At the nadir of her illness she was bed-bound, aphasic with a right hemiparesis. In addition she exhibited subtle jerking of her right arm and face and reduced responsiveness and was considered to be in nonconvulsive status clinically but not proven to be so electrographically. A trial of Rituximab was commenced with weekly injections over a four-week period. This resulted in a clear and sustained improvement in arm function, speech output and in seizure frequency and severity. At the time of discharge, her speech was understandable though not fluent and she had begun to mobilise, taking a few steps with help.
Discussion
This case satisfies the published criteria for the diagnosis of Rasmussen's encephalitis without the requirement for a brain biopsy [2] . In addition, the protracted clinical course and minimal hemiparesis are all in keeping with previously reported adult onset cases of RE. This case expands the phenotypic spectrum of symptomatic reflex epilepsies manifesting as focal seizures with dysphasia. Although dysphasia is a common manifestation of RE with involvement of the dominant hemisphere, reflex activation of epileptic discharges by language has not been previously described in RE. A notable feature of the patient's reflex epilepsy was precipitation by either listening to language or reading, but not by her own speech. The stimulus sensitive anatomical correlates for reading and auditory processing are located within the posterior temporal-parietal-occipital area, whilst those that subserve vocalisation or language production are located in the dominant prefrontal cortex. Speculatively, activation of the latter with verbal generation by self may reciprocally deactivate, modify or even suppress ictal neuronal activity in the temporal cortex.
In our case, interictal discharges and ictal spike and polyspike discharges were observed following induction of reflex partial seizures; but on another occasion, when she was considered clinically to be in non-convulsive status, with subtle right-sided jerking and reduced responsiveness, the EEG, whilst abnormal with epileptiform discharges predominantly left sided, was not interpreted as showing non-convulsive status. This may be explained by the multifocal nature of the epileptiform discharges.
The treatment of RE remains challenging. Seizures, particularly EPC tend to be refractory to AEDs. Immunomodulatory treatments including corticosteroids, intravenous immunoglobulin, plasma exchange and Tacrolimus have all demonstrated efficacy, although the effects may be transient [3] . The use of biological agents may hold promise for the future. Natalizumab was reported to result in improvement of focal seizures and EPC in an adult-onset case of RE [4] . More recently in an open study, Adalimumab demonstrated efficacy against seizures when tested in 11 individuals with RE [5] .
We observed a clear symptomatic improvement in our case following treatment with Rituximab, in agreement with previously published reports. In a pilot study of RTX use to treat RE, eight out of nine patients exhibited some reduction in seizure frequency (50-100%) and severity as well as improvements in motor and cognitive function [6] . Accumulating data on the efficacy of RTX in RE is of considerable interest, although the number of reported cases is small. Larger studies are needed to establish both its long term safety and efficacy. Moreover, the question of whether its earlier introduction may have a greater impact on arresting the underlying process particularly in adult onset cases which typically exhibit a more protracted course needs consideration.
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